Clinical trials for Rhabdomyosarcoma
15 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONNCT07449949A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus RhabdomyosarcomaEye & ENT Hospital of Fudan University
- RECRUITINGPhase 1NCT06865664FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory RhabdomyosarcomaNational Cancer Institute (NCI) · PI: Srivandana Akshintala, M.D.
- RECRUITINGNCT06924463Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass SpectrometryLille University
- RECRUITINGPHASE1, PHASE2NCT06456892Effectiveness of Pucotenlimab Combined With Standard Chemotherapy RegimenSun Yat-sen University
- RECRUITINGPhase 2NCT06023641Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseSt. Jude Children's Research Hospital · PI: Alberto Pappo, MD
- RECRUITINGPhase 2NCT05457829Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical StudySun Yat-sen University · PI: Yizhuo Zhang, PhD
- RECRUITINGPHASE1, PHASE2NCT04796012VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid TumorsUniversity of Texas Southwestern Medical Center · PI: Arhanti Sadanand, MD
- RECRUITINGPhase 1NCT04995003HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced SarcomaBaylor College of Medicine · PI: Meenakshi Hegde, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04388839Evolutionary Therapy for RhabdomyosarcomaH. Lee Moffitt Cancer Center and Research Institute · PI: Jonathan Metts, MD
- RECRUITINGPHASE1, PHASE2NCT04625907FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaUniversity of Birmingham · PI: Meriel Jenney
- ACTIVE NOT RECRUITINGPhase 1NCT04299113Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaJonsson Comprehensive Cancer Center · PI: Noah C. Federman, MD
- ENROLLING BY INVITATIONPhase 1NCT03054792Molecular-Functional Imaging of Hypoxia in Childhood SarcomasThe Hospital for Sick Children
- RECRUITINGPhase 3NCT06836492A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.Yizhuo Zhang
- ACTIVE NOT RECRUITINGPhase 2NCT01871766Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapySt. Jude Children's Research Hospital · PI: Matthew J. Krasin, MD
- ACTIVE NOT RECRUITINGPhase 2NCT00186992Radiation Therapy to Treat Musculoskeletal TumorsSt. Jude Children's Research Hospital · PI: Matthew Krasin, MD